Xtant Medical to Issue Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 24, 2021
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for the fourth quarter and full year ended December 31, 2020, on February 24, 2021, before market open.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Xtant Medical Holdings, Inc. (NYSE American: XTNT) will release its financial results for the fourth quarter and full year ended December 31, 2020, on February 24, 2021, before market open. The results will be discussed in a conference call at 9:00 AM ET the same day, led by CEO Sean Browne and CFO Greg Jensen. Investors can join the call at 877-407-6184 or through international dial-in at 201-389-0877. A replay will be available on the company's website post-call. Xtant Medical specializes in surgical solutions for spinal disorders.
Positive
- Scheduled release of Q4 and full year 2020 financial results may indicate a commitment to transparency and performance evaluation.
- Leadership engagement in the upcoming conference call suggests proactive communication with investors.
Negative
- None.
Details
News Market Reaction – XTNT
The recorded move for XTNT in the trading session of this news was +16.84%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the fourth quarter and full year ended December 31, 2020, before the open of the financial markets on Wednesday, February 24, 2021.
Sean Browne, President and Chief Executive Officer, and Greg Jensen, Vice President, Finance and Chief Financial Officer, will host a conference call on Wednesday, February 24 at 9:00 AM ET to review results.
Conference Call Details
Date: Wednesday, February 24, 2021 – 9:00 AM ET
Dial-in: 877-407-6184
International dial-in: 201-389-0877
Conference Call Name: Xtant Medical Fourth Quarter 2020 Financial Results
Webcast Registration: Click Here
Following the live call, a replay will be available on the Company’s website, www.xtantmedical.com, under “Investor Info.”
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Investor Relations Contact
David Carey
Lazar FINN Partners
Ph: 212-867-1768
Email: david.carey@finnpartners.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.